Finance

Beta
Lists
NEWBRY:STO
Newbury Pharmaceuticals AB
SEK 2.03
-10.96%
(-0.25) 1D
Jun 5, 4:38:34 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for NEWBRY...
Open
SEK 2.28
High
SEK 2.28
Low
SEK 2.01
Mkt. cap
61.71M
Avg. vol.
69.97K
Volume
74.03K
52-wk high
SEK 7.88
52-wk low
SEK 0.76
EPS
-SEK 0.99
Shares outstanding
30.40M
No. of employees
7
Open
SEK 2.28
High
SEK 2.28
Low
SEK 2.01
Mkt. cap
61.71M
Avg. vol.
69.97K
Volume
74.03K
52-wk high
SEK 7.88
52-wk low
SEK 0.76
EPS
-SEK 0.99
Shares outstanding
30.40M
No. of employees
7
News stories
From sources across the web
About Newbury Pharmaceuticals AB
CEO-
Employees7
Founded2020
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
6.69M
5.92M
11.72M
8.45M
Cost of goods sold
4.40M
5.49M
8.58M
5.62M
Cost of revenue
4.40M
5.49M
8.58M
5.62M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.50M
5.38M
8.97M
6.48M
Operating expense
8.97M
6.80M
9.74M
7.41M
Total operating expenses
13.37M
12.30M
18.33M
13.04M
Operating income
-6.68M
-6.38M
-6.61M
-4.58M
Other non operating income
518.00K
-2.39M
487.00K
439.00K
EBT including unusual items
-6.58M
-10.54M
-6.53M
-4.56M
EBT excluding unusual items
-6.58M
-9.99M
-6.53M
-4.56M
Income tax expense
-
281.00K
-
-
Effective tax rate
-
-2.67%
-
-
Other operating expenses
2.00M
-2.83M
174.00K
465.00K
Net income
-6.58M
-10.82M
-6.53M
-4.56M
Net profit margin
-98.38%
-182.87%
-55.73%
-53.90%
Earnings per share
-
-
-
-
Interest and investment income
-
16.00K
-
-
Interest expense
-413.00K
-423.00K
-412.00K
-413.00K
Net interest expenses
-413.00K
-407.00K
-412.00K
-413.00K
Depreciation and amortization charges
474.00K
4.25M
595.00K
464.00K
EBITDA
-6.21M
-2.13M
-6.01M
-4.20M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more